Document is current
Any future updates will be listed below
-
Authors
Rezaei, Ali https://orcid.org/0000-0001-8974-1304
Kocsis-Jutka, Virág
Gunes, Zeynep I. https://orcid.org/0000-0002-4720-8226
Zeng, Qing https://orcid.org/0000-0003-0574-1310
Kislinger, Georg https://orcid.org/0000-0002-6559-7421
Bauernschmitt, Franz
Isilgan, Huseyin Berkcan https://orcid.org/0000-0003-3369-1453
Parisi, Laura R.
Kaya, Tuğberk
Franzenburg, Sören https://orcid.org/0000-0001-6374-4910
Koppenbrink, Jonas
Knogler, Julia
Arzberger, Thomas
Farny, Daniel
Nuscher, Brigitte
Katona, Eszter
Dhingra, Ashutosh
Yang, Chao
Gouna, Garyfallia https://orcid.org/0000-0002-4644-8252
LaClair, Katherine D. https://orcid.org/0000-0001-5052-2972
Janjic, Aleksandar
Enard, Wolfgang
Zhou, Qihui https://orcid.org/0000-0001-5733-9820
Hagan, Nellwyn
Ofengeim, Dimitry https://orcid.org/0000-0003-2348-3642
Beltrán, Eduardo https://orcid.org/0000-0002-7266-4098
Gokce, Ozgun
Simons, Mikael https://orcid.org/0000-0001-5329-192X
Liebscher, Sabine https://orcid.org/0000-0001-5633-8981
Edbauer, Dieter https://orcid.org/0000-0002-7186-4653
- License Information
-
More Information
Article History
Received: 13 March 2024
Accepted: 27 March 2025
First Online: 11 April 2025
Competing interests
: L.R.P., N.H., and D.O. are employees of Sanofi, but Sanofi is not actively developing CD-based therapeutics. The remaining authors declare no competing interests.
